BRCA1 and cancer: A better understanding of the circulating factors mediating cell-nonautonomous effects of the BRCA1 mutation carrier state should also lead to the identification of novel biomarkers of cancer risk predisposition, facilitating evaluation of cancer risk in germline mutation carriers.